2,872
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Brugada syndrome

, &
Pages 805-824 | Received 17 Jun 2020, Accepted 28 Jun 2020, Published online: 20 Jul 2020

References

  • Adler A. Brugada syndrome: diagnosis, risk stratification, and management. Curr Opin Cardiol. 2016;31(1):37–45.
  • Brugada J, Campuzano O, Arbelo E, et al. Present status of brugada syndrome: JACC state-of-the–art review. J Am Coll Cardiol. 2018;72(9):1046–1059.
  • Bartos DC, Grandi E, Ripplinger CM. Ion channels in the heart. Compr Physiol. 2015;5(3):1423–1464.
  • Klabunde RE. Cardiac electrophysiology: normal and ischemic ionic currents and the ECG. Adv Physiol Educ. 2017;41(1):29–37.
  • John AD, Fleisher LA. Electrocardiography: the ECG. Anesthesiol Clin. 2006;24(4):697–715.
  • Di Diego JM, Antzelevitch C. Acute myocardial ischemia: cellular mechanisms underlying ST segment elevation. J Electrocardiol. 2014;47(4):486–490.
  • Mazzanti A, Priori SG. Brugada syndrome: the endless conundrum. J Am Coll Cardiol. 2016;68(6):624–625.
  • Antzelevitch C, Patocskai B. Brugada syndrome: clinical, genetic, molecular, cellular, and ionic aspects. Curr Probl Cardiol. 2016;41(1):7–57.
  • Juang JM, Huang SK. Brugada syndrome–an under-recognized electrical disease in patients with sudden cardiac death. Cardiology. 2004;101(4):157–169.
  • Polovina MM, Vukicevic M, Banko B, et al. Brugada syndrome: a general cardiologist’s perspective. Eur J Intern Med. 2017;44:19–27.
  • Vatta M, Dumaine R, Varghese G, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet. 2002;11(3):337–345.
  • Postema PG. About Brugada syndrome and its prevalence. Europace. 2012;14(7):925–928.
  • Sieira J, Brugada P. The definition of the Brugada syndrome. Eur Heart J. 2017;38(40):3029–3034.
  • Quan X-Q, Li S, Liu R, et al. A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death. Medicine. 2016;95(50):e5643.
  • Miyasaka Y, Tsuji H, Yamada K, et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol. 2001;38(3):771–774.
  • Brugada R, Campuzano O, Sarquella-Brugada G, et al. Brugada syndrome. Methodist Debakey Cardiovasc J. 2014;10(1):25–28.
  • Matsuo K, Akahoshi M, Seto S, et al. Disappearance of the Brugada-type electrocardiogram after surgical castration: a role for testosterone and an explanation for the male preponderance. Pacing Clin Electrophysiol. 2003;26(7 Pt 1):1551–1553.
  • Shimizu W, Matsuo K, Kokubo Y, et al. Sex hormone and gender difference–role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol. 2007;18(4):415–421.
  • Milman A, Gourraud J-B, Andorin A, et al. Gender differences in patients with Brugada syndrome and arrhythmic events: data from a survey on arrhythmic events in 678 patients. Heart Rhythm. 2018;15(10):1457–1465.
  • Vohra J, Rajagopalan S. Update on the diagnosis and management of brugada syndrome. Heart Lung Circ. 2015;24(12):1141–1148.
  • Sieira J, Dendramis G, Brugada P. Pathogenesis and management of Brugada syndrome. Nat Rev Cardiol. 2016;13(12):744–756.
  • Di Grande A, Tabita V, Lizzio MM, et al. Early repolarization syndrome and Brugada syndrome: is there any linkage? Eur J Intern Med. 2008;19(4):236–240.
  • Patocskai B, Antzelevitch C. Novel therapeutic strategies for the management of ventricular arrhythmias associated with the brugada syndrome. Expert Opin Orphan Drugs. 2015;3(6):633–651.
  • Corrado D, Migliore F, Zorzi A. Brugada syndrome: in search of a cause. J Am Coll Cardiol. 2018;72(22):2758–2760.
  • Nademanee K, Raju H, de Noronha SV, et al. Fibrosis, connexin-43, and conduction abnormalities in the brugada syndrome. J Am Coll Cardiol. 2015;66(18):1976–1986.
  • Corrado D, Zorzi A, Cerrone M, et al. Relationship between arrhythmogenic right ventricular cardiomyopathy and brugada syndrome: new insights from molecular biology and clinical implications. Circ Arrhythm Electrophysiol. 2016;9(4):e003631.
  • Boukens BJD, Christoffels VM, Coronel R, et al. Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias. Circ Res. 2009;104(1):19–31.
  • Elizari MV, Levi R, Acunzo RS, et al. Abnormal expression of cardiac neural crest cells in heart development: a different hypothesis for the etiopathogenesis of brugada syndrome. Heart Rhythm. 2007;4(3):359–365.
  • Sotoodehnia N, Isaacs A, de Bakker PIW, et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010;42(12):1068–1076.
  • Hu D, Barajas-Martínez H, Pfeiffer R, et al. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J Am Coll Cardiol. 2014;64(1):66–79.
  • Behr ER, Savio-Galimberti E, Barc J. et al. Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study. Cardiovasc Res. 2015;106(3):520–529.
  • Abriel H. Genetic background of Brugada syndrome is more complex than what we would like it to be!. Cardiovasc Res. 2015;106(3):351–352.
  • Bezzina CR, Barc J, Mizusawa Y, et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet. 2013;45(9):1044–1049.
  • Nakano Y, Ochi H, Onohara Y, et al. Common variant near HEY2 has a protective effect on ventricular fibrillation occurrence in brugada syndrome by regulating the repolarization current. Circ Arrhythm Electrophysiol. 2016;9(1):e003436.
  • Sarquella-Brugada G, Campuzano O, Arbelo E, et al. Brugada syndrome: clinical and genetic findings. Genet Med. 2016;18(1):3–12.
  • Campuzano O, Fernández-Falgueras A, Iglesias A, et al. Brugada Syndrome and PKP2: evidences and uncertainties. Int J Cardiol. 2016;214:403–405.
  • Olesen MS, Jensen NF, Holst AG, et al. A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias. Can J Cardiol. 2011;27(4):523.e17–523.e23.
  • Ishikawa T, Sato A, Marcou CA, et al. A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. Circ Arrhythm Electrophysiol. 2012;5(6):1098–1107.
  • Probst V, Gourraud JB. Quinidine in brugada syndrome: still a long way to go…. Circ Arrhythm Electrophysiol. 2015;8(6):1309–1310.
  • Olesen MS, Holst AG, Svendsen JH, et al. SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation. Heart Rhythm. 2012;9(5):770–773.
  • Bao Y, Willis BC, Frasier CR, et al. Scn2b deletion in mice results in ventricular and atrial arrhythmias. Circ Arrhythm Electrophysiol. 2016;9(12):pii:e003923.
  • Kurakami K, Ishii K. Is a novel SCN3B mutation commonly found in SCN5A-negative Brugada syndrome patients? Circ J. 2013;77(4):900–901.
  • Ishikawa T, Takahashi N, Ohno S, et al. Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J. 2013;77(4):959–967.
  • Hu D, Barajas-Martinez H, Burashnikov E, et al. A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet. 2009;2(3):270–278.
  • Bissay V, Van Malderen SCH, Keymolen K, et al. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies. Eur J Hum Genet. 2016;24(3):400–407.
  • Cordeiro JM, Marieb M, Pfeiffer R, et al. Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. J Mol Cell Cardiol. 2009;46(5):695–703.
  • Liu H, Chatel S, Simard C, et al. Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel. PLoS One. 2013;8(1):e54131
  • Giudicessi JR, Ye D, Tester DJ, et al. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm. 2011;8(7):1024–1032.
  • Medeiros-Domingo A, Tan B-H, Crotti L, et al. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm. 2010;7(10):1466–1471.
  • David J-P, Lisewski U, Crump SM, et al. Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular KV currents and predisposes to ventricular arrhythmia. Faseb J. 2019;33(2):2537–2552.
  • Hu D, Barajas-Martínez H, Terzic A, et al. ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. Int J Cardiol. 2014;171(3):431–442.
  • Ueda K, Hirano Y, Higashiuesato Y, et al. Role of HCN4 channel in preventing ventricular arrhythmia. J Hum Genet. 2009;54(2):115–121.
  • Moosmang S, Stieber J, Zong X, et al. Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur J Biochem. 2001;268(6):1646–1652.
  • Castro Hevia J, Dorantes Sanchez M, Martinez Lopez F, et al. Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome. Int J Cardiol. 2019;277:130–135.
  • Shimeno K, Takagi M, Maeda K, et al. Usefulness of multichannel Holter ECG recording in the third intercostal space for detecting type 1 Brugada ECG: comparison with repeated 12-lead ECGs. J Cardiovasc Electrophysiol. 2009;20(9):1026–1031.
  • Ueoka A, et al. Prognostic significance of the sodium channel blocker test in patients with Brugada syndrome. J Am Heart Assoc. 2018;7(10):e008617.
  • Antzelevitch C, et al. J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Europace. 2017;19(4):665–694.
  • Sroubek J, Probst V, Mazzanti A, et al. Programmed ventricular stimulation for risk stratification in the brugada syndrome: a pooled analysis. Circulation. 2016;133(7):622–630.
  • Wu W, Tian L, Ke J, et al. Risk factors for cardiac events in patients with Brugada syndrome: a PRISMA-compliant meta-analysis and systematic review. Medicine (Baltimore). 2016;95(30):e4214.
  • Conte G, de Asmundis C, Sieira J, et al. Prevalence and clinical impact of early repolarization pattern and qrs-fragmentation in high-risk patients with brugada syndrome. Circ J. 2016;80(10):2109–2116.
  • Rattanawong P, Riangwiwat T, Prasitlumkum N, et al. Baseline fragmented QRS increases the risk of major arrhythmic events in Brugada syndrome: systematic review and meta-analysis. Ann Noninvasive Electrocardiol. 2018;23(2):e12507.
  • Arbelo E, Brugada J. Risk stratification and treatment of brugada syndrome. Curr Cardiol Rep. 2014;16(7):508
  • Zumhagen S, Zeidler EM, Stallmeyer B, et al. Tpeak-tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome. Europace. 2016;18(12):1866–1872.
  • Pappone C, Santinelli V. Implantable cardioverter defibrillator and catheter ablation in Brugada syndrome. J Cardiovasc Med, 2017;18 (Suppl 1):e35–e39.
  • Gonzalez Corcia MC, Sieira J, Pappaert G, et al. A clinical score model to predict lethal events in young patients (≤19 Years) with the Brugada Syndrome. Am J Cardiol. 2017;120(5):797–802.
  • Dores H, Reis Santos K, Adragão P, et al. Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator. Rev Port Cardiol. 2015;34(6):395–402.
  • Shelke A, Tachil A, Saggu D, et al. Catheter ablation for electrical storm in Brugada syndrome: results of substrate based ablation. Indian Heart J. 2018;70(2):296–302.
  • Argenziano M, Antzelevitch C. Recent advances in the treatment of Brugada syndrome. Expert Rev Cardiovasc Ther. 2018;16(6):387–404.
  • Shen T, Yuan B, Geng J, et al. Low-dose quinidine effectively reduced shocks in Brugada syndrome patients with an implantable cardioverter defibrillator: a Chinese case series report. Ann Noninvasive Electrocardiol. 2017;22(1):e12375.
  • Belhassen B, Rahkovich M, Michowitz Y, et al. Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs. Circ Arrhythm Electrophysiol. 2015;8(6):1393–1402.
  • Marquez MF, et al. Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. Heart Rhythm. 2012;9(12):1995–2000.
  • Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932–1963.
  • Maury P, Couderc P, Delay M, et al. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace. 2004;6(2):130–133.
  • Pappone C, Brugada J. Ventricular arrhythmias ablation in Brugada syndrome. current and future directions. Rev Esp Cardiol. 2017;70(12):1046–1049.
  • Fernandes GC, Fernandes A, Cardoso R, et al. Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review. Heart Rhythm. 2018;15(8):1140–1147.
  • Gottschalk BH, Anselm DD, Baranchuk A. Brugada phenocopies are the leading differential diagnosis of Brugada syndrome. Clin Med. 2015;15(3):308–309.
  • Perez-Riera AR, et al. Brugada phenocopy caused by a compressive mediastinal tumor. Ann Noninvas Electro. 2018;23(3):e12509.
  • Monti M, Olivi G, Francavilla F, et al. Pericarditis mimicking Brugada syndrome. Am J Emerg Med. 2017;35(4):669.e1–e3.
  • Dendramis G. Coronary anomalies and Brugada phenocopy, the first documented case in the world. Int J Cardiol. 2015;199:335–336.
  • Aksu U, Kalkan K, Gulcu O, et al. Massive pulmonary embolism mimicking electrocardiographic pattern of Brugada syndrome. Am J Emerg Med. 2016;34(5):933.e1–933.e2.
  • Xu G, Gottschalk BH, Anselm DD, et al. Relation of the Brugada Phenocopy to Hyperkalemia (from the International Registry on Brugada Phenocopy). Am J Cardiol. 2018;121(6):715–717.
  • Baranchuk A, Nguyen T, Ryu MH, et al. Brugada phenocopy: new terminology and proposed classification. Ann Noninvas Electro. 2012;17(4):299–314.
  • Gottschalk BH, Anselm DD, Brugada J, et al. Expert cardiologists cannot distinguish between Brugada phenocopy and Brugada syndrome electrocardiogram patterns. Europace. 2016;18(7):1095–1100.
  • Anselm DD, Gottschalk BH, Baranchuk A. Brugada phenocopies: consideration of morphologic criteria and early findings from an international registry. Can J Cardiol. 2014;30(12):1511–1515.
  • Tome G, Freitas J. Induced Brugada syndrome: possible sources of arrhythmogenesis. Rev Port Cardiol. 2017;36(12):945–956.
  • Postema PG, Wolpert C, Amin AS, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm. 2009;6(9):1335–1341.
  • Yap YG, Behr ER, Camm AJ. Drug-induced Brugada syndrome. Europace. 2009;11(8):989–994.
  • Gentille-Lorente DI, Lechuga-Duran I. Brugada type 1 pattern and lithium therapy. Actas Esp Psiquiatr. 2015;43(6):235–236.
  • Ondrejka J, Giorgio G. Type 1 Brugada pattern associated with nicotine toxicity. J Emerg Med. 2015;49(6):e183–e186.
  • Romero-Puche AJ, Trigueros-Ruiz N, Cerdán-Sánchez MC, et al. Brugada electrocardiogram pattern induced by cannabis. Rev Esp Cardiol, 2012;65(9):856–858.
  • Letsas KP, Kavvouras C, Kollias G, et al. Drug-induced Brugada syndrome by noncardiac agents. Pacing Clin Electrophysiol. 2013;36(12):1570–1577.
  • Takigawa M, Noda T, Shimizu W, et al. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm. 2008;5(11):1523–1527.
  • Makimoto H, Nakagawa E, Takaki H, et al. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol. 2010;56(19):1576–1584.
  • Littmann L, Monroe MH, Taylor L, et al. The hyperkalemic Brugada sign. J Electrocardiol. 2007;40(1):53–59.
  • Alanzalon RE, Burris JR, Vinocur JM. Brugada phenocopy associated with diabetic ketoacidosis in two pediatric patients. J Electrocardiol. 2018;51(2):323–326.
  • Kovacic JC, Kuchar DL. Brugada pattern electrocardiographic changes associated with profound electrolyte disturbance. Pacing Clin Electrophysiol. 2004;27(7):1020–1023.
  • Tamene A, Sattiraju S, Wang K, et al. Brugada-like electrocardiography pattern induced by severe hyponatraemia. Europace. 2010;12(6):905–907.
  • Sonoda K, Watanabe H, Hisamatsu T, et al. High frequency of early repolarization and brugada-type electrocardiograms in hypercalcemia. Ann Noninvasive Electrocardiol. 2016;21(1):30–40.
  • Madeira M, Caetano F, Providência R, et al. Fever-induced type 1 Brugada pattern. Rev Port Cardiol. 2015;34(4):287.e1-7–287.e7.
  • Adler A, Topaz G, Heller K, et al. Fever-induced Brugada pattern: how common is it and what does it mean? Heart Rhythm. 2013;10(9):1375–1382.
  • Mizusawa Y, Morita H, Adler A, et al. Prognostic significance of fever-induced Brugada syndrome. Heart Rhythm. 2016;13(7):1515–1520.
  • Viswanathan S, Aghoram R. Brugada syndrome in patients with acute febrile illness. Indian Heart J. 2018;70(3):416–420.
  • Baranchuk A, Simpson CS. Brugada syndrome coinciding with fever and pandemic (H1N1) influenza. CMAJ. 2011;183(5):582.
  • Kusaka K, Yamakawa J, Kawaura K, et al. Brugada-like electrocardiographic changes during influenza infection. J Int Med Res. 2003;31(3):244–246.
  • Vieira MB, et al. Fever-triggered Brugada syndrome in an adult patient presenting with hemophagocytic syndrome induced by Chlamydophila pneumoniae. BMJ Case Rep. 2015;2015:pii:bcr2014208863.
  • Pfirman KS, White CA, Kelil A, et al. Brugada syndrome manifesting only during fever in patient with septic shock secondary to post-obstructive pneumonia. Am J Case Rep. 2018;19:1311–1316.
  • Michowitz Y, Milman A, Sarquella-Brugada G, et al. Fever-related arrhythmic events in the multicenter survey on arrhythmic events in Brugada syndrome. Heart Rhythm. 2018;15(9):1394–1401.
  • Singhal T. A review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281–286.
  • Kannan S, Shaik Syed Ali P, Sheeza A, et al. COVID-19 (Novel Coronavirus 2019) – recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006–2011.
  • Giwa AL, Desai A, Duca A. Novel coronavirus COVID-19: an overview for emergency clinicians. Emerg Med Pract. 2020;22(5):1–21.
  • Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
  • Chang D, Saleh M, Garcia-Bengo M, et al. COVID-19 infection unmasking Brugada syndrome. HeartRhythm Case Rep. 2020;6:237–240.
  • Sorgente A, Capulzini L, Brugada P. The known into the unknown: Brugada syndrome and COVID-19. JACC Case Rep. 2020, Epublished. DOI:https://doi.org/10/1016/j.jaccas.2020.04.06.
  • Wu C-I, Postema PG, Arbelo E, et al. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes. Heart Rhythm. 2020;S1547-5271(20)30285-30292.DOI:https://doi.org/10.1016/j.hrthm.2020.03.024
  • Cerrone M. Controversies in Brugada syndrome. Trends Cardiovasc Med. 2018;28(4):284–292.
  • Bassil G, Noujaim SF. Editorial commentary: Brugada syndrome or not? That is the question. Trends Cardiovasc Med. 2018;28(4):293–294.
  • Gonzalez Corcia MC, Sieira J, Sarkozy A, et al. Brugada syndrome in the young: an assessment of risk factors predicting future events. Europace. 2017;19(11):1864–1873.
  • Zheng Y-Y, Ma Y-T, Zhang J-Y, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260.
  • Hu H, Ma F, Wei X, et al. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020, Epublished. DOI:https://doi.org/10/1093/eurheartj/ehaa190

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.